此次集采于2022年9月正式启动，由湖北牵头，北京、天津等30个省级行政单位参与。集采涉及16个品种，共296款剂型、规格不一的药品，被业内认为是中成药的“国采”。中选企业包括益佰制药、吉林敖东、众生药业、科伦药业等多家上市药企。

zhideyitideshi，shuangfangtonghuachixule1gexiaoshi。wukelanzongtongbangongshipingjiazhongwuyuanshoutonghua“changshijianqieyouyiyi”；wuzongtongzeliansijizaishejiaomeitishangfawenbiaoshi，xiangxinyuzhongguolingdaorendetonghuayijiwukelanzhuhuadashiderenming“jiangweiwomenshuangbianguanxidefazhantigongqiangyoulidedongli”。值(zhi)得(de)一(yi)提(ti)的(de)是(shi)，(，)双(shuang)方(fang)通(tong)话(hua)持(chi)续(xu)了(le)1(1)个(ge)小(xiao)时(shi)。(。)乌(wu)克(ke)兰(lan)总(zong)统(tong)办(ban)公(gong)室(shi)评(ping)价(jia)中(zhong)乌(wu)元(yuan)首(shou)通(tong)话(hua)“(“)长(chang)时(shi)间(jian)且(qie)有(you)意(yi)义(yi)”(”)；(；)乌(wu)总(zong)统(tong)泽(ze)连(lian)斯(si)基(ji)在(zai)社(she)交(jiao)媒(mei)体(ti)上(shang)发(fa)文(wen)表(biao)示(shi)，(，)相(xiang)信(xin)与(yu)中(zhong)国(guo)领(ling)导(dao)人(ren)的(de)通(tong)话(hua)以(yi)及(ji)乌(wu)克(ke)兰(lan)驻(zhu)华(hua)大(da)使(shi)的(de)任(ren)命(ming)“(“)将(jiang)为(wei)我(wo)们(men)双(shuang)边(bian)关(guan)系(xi)的(de)发(fa)展(zhan)提(ti)供(gong)强(qiang)有(you)力(li)的(de)动(dong)力(li)”(”)。(。)